Exclusive

Publication

Byline

Location

Charles River Signs Strategic MOUs To Strengthen APAC Biomanufacturing Ecosystem

Singapore, March 10 -- Charles River Laboratories reinforced its commitment to strengthening the Asia Pacific biomanufacturing ecosystem by signing a series of strategic Memorandums of Understanding d... Read More


Charles River Led Panel Examines How APAC Can Strengthen Global Competitiveness In Biomanufacturing

Singapore, March 10 -- As global demand for biologics, advanced therapies, and complex biopharmaceuticals continues to expand, the conversation around competitiveness in biomanufacturing is rapidly sh... Read More


Analytical Characterisation Strengthens Biologics Development From Molecule To Market

Singapore, March 10 -- At the APAC Biomanufacturing Leadership Summit 2026 presented by Charles River, Zelle Biotechnology Managing Director Anurag Tulsyan highlights the critical role of analytical s... Read More


Pfizer, ASKA Pharma to co-promote RSV vaccine Abrysvo in Japan

Singapore, March 10 -- Pfizer Japan Inc., and ASKA Pharmaceutical have announced that they will begin co-promotion of the Respiratory Syncytial Virus (RSV) vaccine "ABRYSVO(R) intramuscular injection"... Read More


Australia's CSL announces expansion of US plasma therapy manufacturing facility with $1.5 B investment

Singapore, March 10 -- CSL, an Australia-based global biopharma leader, broke ground for the expansion of its state-of-the-art manufacturing facility in Kankakee, Illinois in the US. The expansion, a ... Read More


BioDuro enters Taiwan joint venture to expand resilient global API manufacturing capacity

Singapore, March 9 -- US-based BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), has established a joint venture with Cenra API Solutions, also as kno... Read More


Sartorius unveils new genetically engineered CHO host cell line

Singapore, March 9 -- US-based Sartorius is addressing the increasing demand for faster and more efficient cell line development (CLD) by launching a new genetically engineered CHO host cell line that... Read More


Australia injects $21 M into first oral therapeutic for restoring gut lymphatic function

Singapore, March 6 -- Australia's Monash University has announced the award of support from the Advanced Research Projects Agency for Health (ARPA-H) to advance an oral prodrug of celecoxib - using th... Read More


Grunenthal licenses exclusive South Korean rights of Qutenza(R) to BCWorld Pharm for pain management

Singapore, March 5 -- Germany-based Grunenthal, a global leader in pain management and related diseases, and South Korea's BCWorld Pharm (BCWP), a specialty company actively expanding and diversifying... Read More


Australia's Monash University licences therapeutic programme to CSL

Singapore, March 5 -- Monash University has entered into a licensing agreement with CSL, marking a significant outcome that reflects the University's ambition and growing success in research translati... Read More